Like this:
• The maximum tolerated dose established in these studies is significantly higher than
doses to be used in the Phase 1 clinical trial, thereby reducing the likelihood of an
adverse event occurring during the Phase 1 trial.
Ann: Maximum Tolerated Dose Successfully Established in Studies, page-2
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.5¢ |
Change
-0.015(1.88%) |
Mkt cap ! $99.79M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 81.0¢ | 78.5¢ | $26.08K | 32.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10299 | 78.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 6713 | 1 |
View Market Depth
| Last trade - 15.53pm 04/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |